INTERFACE BIOLOGICS, INC.
Interface Biologics, Inc. (IBI) is a commercial stage company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices. Their patent-protected technologies include anti-thrombogenic additives for blood contacting medical devices and polymer enabled combination drug delivery devices. IBI has exclusive Endexo™ technology licensing agreements with AngioDynamics for vascular access catheters and with Fresenius Medical Care for chronic... dialysis systems. AngioDynamics’ BioFlo PICCS, Ports and DuraMax Dialysis Catheter with IBI’s Endexo technology have received FDA clearance and are gaining commercial traction. IBI also has a joint venture commercial agreement with Qualimed to develop a drug-coated balloon based on IBI’s Kinesyx™ technology. The company was founded in 2001 and is headquartered in Toronto, Canada at the acclaimed MaRS Innovation Centre.
INTERFACE BIOLOGICS, INC.
Social Links:
Industry:
Biotechnology Health Care Medical Device
Founded:
2001-12-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.interfacebiologics.com
Total Employee:
11+
Status:
Active
Contact:
4169771329
Email Addresses:
[email protected]
Total Funding:
32 M USD
Technology used in webpage:
SPF Euro Microsoft Exchange Online Amazon Office 365 Mail GoDaddy DNS Amazon Virginia Region
Similar Organizations
Altaviz
Altaviz develops patent-protected technologies for single-use, custom injection system medical devices.
Aortech International
Aortech International is a biomedical polymer technology, components and medical devices.
Perikinetics
Perikinetics develops an artificial pancreas technology platform to deliver insulin physiologically.
Preciva
Preciva is developing electronic screening tools to give every woman an equal chance to live free of cervical cancer.
Retractable Technologies
Retractable technologies aim to be a catalyst through creativity, education and the production of secure and effective medical devices.
Xillix
Xillix has develops and commercializes medical imaging technologies for detection and localization of cancer.
Current Advisors List
Founder
Investors List
BDC Healthcare Venture
BDC Healthcare Venture investment in Series B - Interface Biologics, Inc.
DSM Venturing
DSM Venturing investment in Series B - Interface Biologics, Inc.
Business Development Bank of Canada
Business Development Bank of Canada investment in Series B - Interface Biologics, Inc.
Covington Group
Covington Group investment in Series B - Interface Biologics, Inc.
BDC Capital Corporation
BDC Capital Corporation investment in Venture Round - Interface Biologics, Inc.
Covington Group
Covington Group investment in Venture Round - Interface Biologics, Inc.
BDC Venture Capital
BDC Venture Capital investment in Seed Round - Interface Biologics, Inc.
Official Site Inspections
http://www.interfacebiologics.com
- Host name: smtp2.innovasium.com
- IP address: 107.21.8.129
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
